Niosomes containing anti-cancer drugs, if
suitably designed, will be expected to
accumulate within tumors in a similar manner
to liposomes. The niosomal encapsulation of
Methotrexate and Doxorubicin increases drug
delivery to the tumor and tumoricidal activity
of the drug. Doxorubicin niosomes possessing
muramic acid and triglycerol surfaces were
not taken up significantly by liver